File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S0304-3835(01)00701-7
- Scopus: eid_2-s2.0-0035935259
- PMID: 11595124
- WOS: WOS:000171238900002
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Exogenous expression of p21WAF1/CIP1 exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells
Title | Exogenous expression of p21WAF1/CIP1 exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells |
---|---|
Authors | |
Keywords | Cisplatin Hep3B Hepatoma cells p21WAF1/CIP1 Transfection |
Issue Date | 2001 |
Publisher | Elsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/canlet |
Citation | Cancer Letters, 2001, v. 172 n. 1, p. 7-15 How to Cite? |
Abstract | The effects of exogenous expression of p21WAF1/CIP1 in hepatoma cells were examined. Two stably p21WAF1/CIP1-transfected clones and one clone transfected with expression vector only were used for study. Introduction of p21WAF1/CIP1 resulted in significant cell growth inhibition, and the magnitude of the cell growth inhibition in these transfected cells was proportional to the level of p21WAF1/CIP1 protein expressed. Exogenous p21WAF1/CIP1 expression also significantly enhanced chemosensitivity to cisplatin. In addition, apoptosis occurred earlier in cells transfected with p21WAF1/CIP1 after cisplatin treatment. These findings raise the potential that forced upregulation of p21WAF1/CIP1 in hepatocellular carcinoma (HCC) may reduce the doses of cisplatin to achieve similar responses and suggest the possible use of p21WAF1/CIP1 in HCC treatment. © 2001 Elsevier Science Ireland Ltd. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/88643 |
ISSN | 2023 Impact Factor: 9.1 2023 SCImago Journal Rankings: 2.595 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Qin, LF | en_HK |
dc.contributor.author | Ng, IOL | en_HK |
dc.date.accessioned | 2010-09-06T09:46:04Z | - |
dc.date.available | 2010-09-06T09:46:04Z | - |
dc.date.issued | 2001 | en_HK |
dc.identifier.citation | Cancer Letters, 2001, v. 172 n. 1, p. 7-15 | en_HK |
dc.identifier.issn | 0304-3835 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/88643 | - |
dc.description.abstract | The effects of exogenous expression of p21WAF1/CIP1 in hepatoma cells were examined. Two stably p21WAF1/CIP1-transfected clones and one clone transfected with expression vector only were used for study. Introduction of p21WAF1/CIP1 resulted in significant cell growth inhibition, and the magnitude of the cell growth inhibition in these transfected cells was proportional to the level of p21WAF1/CIP1 protein expressed. Exogenous p21WAF1/CIP1 expression also significantly enhanced chemosensitivity to cisplatin. In addition, apoptosis occurred earlier in cells transfected with p21WAF1/CIP1 after cisplatin treatment. These findings raise the potential that forced upregulation of p21WAF1/CIP1 in hepatocellular carcinoma (HCC) may reduce the doses of cisplatin to achieve similar responses and suggest the possible use of p21WAF1/CIP1 in HCC treatment. © 2001 Elsevier Science Ireland Ltd. All rights reserved. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Elsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/canlet | en_HK |
dc.relation.ispartof | Cancer Letters | en_HK |
dc.rights | Cancer Letters. Copyright © Elsevier Ireland Ltd. | en_HK |
dc.subject | Cisplatin | - |
dc.subject | Hep3B | - |
dc.subject | Hepatoma cells | - |
dc.subject | p21WAF1/CIP1 | - |
dc.subject | Transfection | - |
dc.subject.mesh | Antineoplastic Agents - pharmacology | en_HK |
dc.subject.mesh | Blotting, Western | en_HK |
dc.subject.mesh | Carcinoma, Hepatocellular - drug therapy | en_HK |
dc.subject.mesh | Cell Cycle - drug effects | en_HK |
dc.subject.mesh | Cell Division - drug effects | en_HK |
dc.subject.mesh | Cisplatin - pharmacology | en_HK |
dc.subject.mesh | Cyclin-Dependent Kinase Inhibitor p21 | en_HK |
dc.subject.mesh | Cyclins - biosynthesis | en_HK |
dc.subject.mesh | DNA Fragmentation | en_HK |
dc.subject.mesh | Dose-Response Relationship, Drug | en_HK |
dc.subject.mesh | Flow Cytometry | en_HK |
dc.subject.mesh | Genes, p53 - genetics | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Liver Neoplasms - drug therapy | en_HK |
dc.subject.mesh | Tetrazolium Salts - pharmacology | en_HK |
dc.subject.mesh | Thiazoles - pharmacology | en_HK |
dc.subject.mesh | Time Factors | en_HK |
dc.subject.mesh | Transfection | en_HK |
dc.subject.mesh | Tumor Cells, Cultured | en_HK |
dc.title | Exogenous expression of p21WAF1/CIP1 exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0304-3835&volume=172&spage=7&epage=15&date=2001&atitle=Exogenous+expression+of+p21WAF1/CIP1+exerts+cell+growth+inhibition+and+enhances+sensitivity+to+cisplatin+in+hepatoma+cells | en_HK |
dc.identifier.email | Ng, IOL:iolng@hkucc.hku.hk | en_HK |
dc.identifier.authority | Ng, IOL=rp00335 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/S0304-3835(01)00701-7 | en_HK |
dc.identifier.pmid | 11595124 | en_HK |
dc.identifier.scopus | eid_2-s2.0-0035935259 | en_HK |
dc.identifier.hkuros | 63378 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0035935259&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 172 | en_HK |
dc.identifier.issue | 1 | en_HK |
dc.identifier.spage | 7 | en_HK |
dc.identifier.epage | 15 | en_HK |
dc.identifier.isi | WOS:000171238900002 | - |
dc.publisher.place | Ireland | en_HK |
dc.identifier.issnl | 0304-3835 | - |